CYP2B6 and metabolic dysfunction-associated steatotic liver disease: In conclusion, the data presented indicates CDAHFD-fed Cyp2b-null female mice are less susceptible to the development of obesity and NAFLD than WT mice, and have less inflammation potentially due to glucocorticoid-mediated repression of immune responses.